Comparison of Endophthalmitis Rates Between Prefilled Syringes and Standard Vials in Aflibercept Intravitreal Injections: A Retrospective Study in Japan

Retinal DiseasesSurgery and InterventionFurther Publications

Non-Pharmacological Aspects of Intravitreal Dexamethasone Implant Injections: A Retrospective Study of 3430 Injections and Complications

Retina

Kiristioglu MO, Gunduz GU, Abdullayeva N, Doganay S, Yalcinbayir O

doi: 10.1097/IAE.0000000000004270

Macular Diseases

Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study

Br J Ophthalmol

Couret C, Quintart PA, Poinas A, Vibet MA, Le Lez ML, Labalette P, Bodaghi B, Labetoulle M, Rougier MB, Angioi K, Chiquet C, Titah C, Kodjikian L, Baillif S, Creuzot-Garcher C, Errera MH, Weber M

doi: 10.1136/bjo-2023-325128

Surgery and InterventionFurther Publications

Intravitreal Antibiotics versus Early Vitrectomy plus Intravitreal Antibiotics for Post-Injection Endophthalmitis: an IRIS® Registry (Intelligent Research in Sight)

Ophthalmol Retina

Ross C, Ghauri S, Gilbert JB, Hu D, Ullanat V, Gong D, Greenberg PB, Eliott D, Elze T, Lorch A, Miller JW, Krzystolik MG, IRIS®; Registry Analytic Center Consortium

doi: 10.1016/j.oret.2024.09.002

Glaucoma and Ocular PressureRetinal Diseases

Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study

Br J Ophthalmol

Paris A, Volpe G, Perruchoud-Ader K, Casanova A, Menghini M, Grimaldi G

doi: 10.1136/bjo-2024-326053

Retinal Diseases

Endophthalmitis Incidence After Intravitreal Injection of Anti-VEGF Agents with Povidone-Iodine vs. Aqueous Chlorhexidine Antisepsis

Ophthalmol Retina

Bates B, Fitzpatrick J, Rosanky C, Moon J, Wood E, Storey P

doi: 10.1016/j.oret.2025.03.022

Macular Diseases

Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST).

Sci Rep

Tsujinaka H, Imoto S, Ueda T, Wakuta M, Yamada Y, Sugisawa T, Murao F, Hirano T, Yoshida S, Kato K, Sasaki M, Matsumoto R, Ishigooka G, Ogata N

doi: 10.1038/s41598-024-69775-9

Macular Diseases

Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration

J Clin Med

Hatz K, Ambresin A, Schmid M, Prünte C, Barthelmes D, Machewitz T, Allmeier H, Somfai GM, XTEND Study Group

doi: 10.3390/jcm14072370

Macular Diseases

Intravitreal anti-vascular endothelial growth factor injections and risks of stroke in patients with neovascular age-related macular degeneration-A registry-based cohort study

Acta Ophthalmol

Falemban AH, Söderberg-Löfdal K, Jonsson F, Almlöf-Sarman S, von Euler M, Westborg I

doi: 10.1111/aos.17534

Glaucoma and Ocular PressureMacular DiseasesRetinal Diseases

Secondary ocular hypertension as an adverse effect of treatment with intravitreal dexamethasone implant: A retrospective Swedish cohort study

Acta Ophthalmol

Abu Ishkheidem I, Breimer M, Kamal S, Zetterberg M, Al-Hawasi A, Grönlund MA

doi: 10.1111/aos.17475

Related content

Non-Pharmacological Aspects of Intravitreal Dexamethasone Implant Injections: A Retrospective Study of 3430 Injections and Complications

Comparison of subconjunctival TRIamcinolone acetonide injection and intravitreal dexamethasone (OZurdex) injection for uveitic and postoperative macular oedema: the TRIOZ study

Intravitreal Antibiotics versus Early Vitrectomy plus Intravitreal Antibiotics for Post-Injection Endophthalmitis: an IRIS® Registry (Intelligent Research in Sight)

Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study

Endophthalmitis Incidence After Intravitreal Injection of Anti-VEGF Agents with Povidone-Iodine vs. Aqueous Chlorhexidine Antisepsis

Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST).

Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration

Intravitreal anti-vascular endothelial growth factor injections and risks of stroke in patients with neovascular age-related macular degeneration-A registry-based cohort study

Secondary ocular hypertension as an adverse effect of treatment with intravitreal dexamethasone implant: A retrospective Swedish cohort study